RNS-60 by Revalesio for Acute Ischemic Stroke: Likelihood of Approval

RNS-60 is under clinical development by Revalesio and currently in Phase II for Acute Ischemic Stroke.

Falls linked to increased risk of dementia in older adults

In a retrospective study of Medicare claims data, researchers found dementia was more frequently diagnosed within one year of a fall compared to other types

September 30, 2024

Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages

Aurobindo, which is one of the largest generic drug makers, has halted some production at a key facility in India after U.S. inspectors found manufacturing

February 9, 2024

BridgeBio partners with biomanufacturer Resilience to produce early-stage AAV gene therapies

BridgeBio has tapped biomanufacturing company National Resilience to produce two of its early-phase adeno-associated virus (AAV) gene therapies in a partnership designed to run beyond

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.